AMEDISYS INC - Common Stock, par value $0.001 per share (AMED)

Historical Holders from Q1 2014 to Q3 2025

Symbol
AMED
Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
32,982,385
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
542
Holdings value
$61,595
% of all portfolios
0%
Number of holders
4
Number of buys
2
Number of sells
-312
Average buys %
+0%
Average sells %
-0.01%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of AMEDISYS INC - Common Stock, par value $0.001 per share (AMED)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
GOLDMAN SACHS GROUP INC 0% -1.1% $19,188 -$178,680,496 190 -100% THE GOLDMAN SACHS GROUP, INC. 30 Sep 2025

Institutional Holders of AMEDISYS INC - Common Stock, par value $0.001 per share (AMED)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 542 $61,595 -$3,244,432,615 $99.8 4
2025 Q2 32,988,261 $3,245,032,619 +$158,439,809 $98.39 318
2025 Q1 31,712,364 $2,937,637,500 -$44,225,875 $92.63 302
2024 Q4 32,072,548 $2,911,289,403 +$45,469,084 $90.79 289
2024 Q3 31,104,840 $3,001,877,264 +$5,995,463 $96.51 282
2024 Q2 31,067,678 $2,853,693,997 +$79,318,831 $91.8 287
2024 Q1 30,596,920 $2,819,745,626 -$78,638,381 $92.16 280
2023 Q4 31,505,475 $2,994,445,626 +$158,414,857 $95.06 285
2023 Q3 29,904,687 $2,793,414,584 -$4,373,774 $93.4 284
2023 Q2 29,980,075 $2,740,518,682 -$71,288,435 $91.44 297
2023 Q1 31,250,815 $2,298,987,210 +$6,757,528 $73.55 276
2022 Q4 31,107,723 $2,599,215,989 -$51,467,952 $83.54 271
2022 Q3 31,547,667 $3,053,632,701 +$111,680,523 $96.79 268
2022 Q2 29,252,616 $3,079,861,282 -$83,631,487 $105.12 271
2022 Q1 30,205,611 $5,201,601,524 +$176,038,628 $172.29 317
2021 Q4 29,255,269 $4,733,452,345 +$74,262,561 $161.88 314
2021 Q3 28,284,976 $4,217,606,134 -$207,742,696 $149.1 340
2021 Q2 28,923,326 $7,084,910,657 +$78,583,021 $244.93 362
2021 Q1 28,502,858 $7,549,005,908 -$67,770,886 $264.79 382
2020 Q4 29,105,018 $8,536,392,508 +$83,416,142 $293.33 392
2020 Q3 28,914,071 $6,828,800,828 -$191,408,695 $236.43 384
2020 Q2 29,715,664 $5,899,715,526 +$146,681,226 $198.54 343
2020 Q1 29,014,408 $5,322,433,405 +$4,554,348 $183.54 323
2019 Q4 29,002,217 $4,841,499,681 -$100,707,757 $166.92 319
2019 Q3 29,784,935 $3,901,788,451 +$121,585,155 $131.01 278
2019 Q2 29,001,205 $3,515,931,567 +$145,221,977 $121.41 282
2019 Q1 28,204,661 $3,475,093,372 -$140,796,705 $123.26 312
2018 Q4 29,394,527 $3,442,699,144 -$109,087,531 $117.11 295
2018 Q3 30,200,704 $3,772,804,638 -$16,330,529 $124.96 264
2018 Q2 30,476,407 $2,604,785,331 -$172,195,789 $85.46 212
2018 Q1 32,707,278 $1,973,226,792 +$27,394,125 $60.34 192
2017 Q4 33,069,925 $1,743,131,691 +$26,735,181 $52.71 186
2017 Q3 32,496,859 $1,818,025,134 -$52,753,282 $55.96 161
2017 Q2 33,045,448 $2,075,329,751 -$3,908,049 $62.81 167
2017 Q1 33,193,909 $1,695,961,518 +$308,926,227 $51.09 152
2016 Q4 32,510,105 $1,385,955,167 +$33,441,800 $42.63 157
2016 Q3 31,684,214 $1,502,497,074 +$69,062,700 $47.44 152
2016 Q2 31,002,719 $1,564,974,191 +$23,317,389 $50.48 165
2016 Q1 30,512,497 $1,474,889,487 +$25,220,606 $48.34 166
2015 Q4 30,164,535 $1,186,345,410 -$2,783,037 $39.32 164
2015 Q3 30,256,083 $1,148,858,026 +$32,918,319 $37.97 170
2015 Q2 29,365,673 $1,166,694,554 +$44,691,262 $39.73 141
2015 Q1 28,315,891 $758,765,807 -$11,413,659 $26.78 129
2014 Q4 28,726,805 $843,051,239 -$23,201,331 $29.35 136
2014 Q3 30,046,900 $606,059,851 -$7,590,031 $20.17 123
2014 Q2 30,581,280 $512,197,698 +$6,069,964 $16.74 121
2014 Q1 30,281,819 $451,104,208 +$10,905,819 $14.89 118